Current Research Studies

Cancer – A031102: Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Refractory Germ Cell Tumors

Condition or Therapy:

Germ cell tumor, teratoma, choricarinoma, germinoma, yolk sac tumor


Cancer and Blood Disorders
Study Number: A031102

What is the goal of this study?

This study looks at how high-dose combination chemotherapy and stem cell transplant compares with standard-dose combination chemotherapy to treat patients with refractory or recurrent germ cell tumors.

Who can join the study?

This study may be a good fit for children and young adults who:

  • are male,
  • 14 years of age or older, and
  • have progressive or recurrent germ cell tumors.

What will happen if my child takes part in this study?

You can read more about this study on

Who can I contact for more information?

To learn more, call 206-987-2106 or email the study coordinator.

Study Location(s):

Seattle Children's Main Hospital Campus

Principal Investigator:

Dr. Douglas Hawkins